1-4 of 4
Xiao Yi Yang
Close
Sort by
Journal Articles

Chemical Genomics Reveals JAK STAT Activation As a Mechanism of Resistance to HDAC Inhibitors in B Cell Lymphomas

Matthew S. McKinney, MD, Anne W Beaven, MD, Andrea Moffitt, Jason Landon Smith, MD, Eric Lock, PhD, Dereje Jima, Jane Healy, MD PhD, Guojie Li, Adrienne Greenough, PhD, Cassandra L Love, MS, Xiao Yi Yang, MD, David Dunson, PhD, Herbert Kim Lyerly, MD, Leon Bernal-Mizrachi, MD, Randy D. Gascoyne, MD, Sandeep S. Dave, MD
Journal: Blood
Blood (2014) 124 (21): 271.
https://doi.org/10.1182/blood.V124.21.271.271
Published: 2014
Journal Articles

Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ

Li Hua Wang, Xiao Yi Yang, Xiaohu Zhang, William L. Farrar
Journal: Blood
Blood (2007) 110 (13): 4373–4384.
https://doi.org/10.1182/blood-2006-07-038026
Published: 2007
Journal Articles

Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells

Li Hua Wang, Robert A. Kirken, Xiao Yi Yang, Rebecca A. Erwin, Luis DaSilva, Cheng-Rong Yu, William L. Farrar
Journal: Blood
Blood (2000) 95 (12): 3816–3822.
https://doi.org/10.1182/blood.V95.12.3816
Published: 2000
Journal Articles

Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4–driven T H 2 cell response

Li Hua Wang, Xiao Yi Yang, Robert A. Kirken, James H. Resau, William L. Farrar
Journal: Blood
Blood (2000) 95 (4): 1249–1257.
https://doi.org/10.1182/blood.V95.4.1249.004k39_1249_1257
Published: 2000